Aoxing Pharmaceutical Company, Inc. (AOXG)
- Previous Close
0.0072 - Open
0.0071 - Bid --
- Ask --
- Day's Range
0.0072 - 0.0072 - 52 Week Range
0.0010 - 0.0139 - Volume
150,000 - Avg. Volume
5,746 - Market Cap (intraday)
2.457M - Beta (5Y Monthly) -54.89
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0000 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Aoxing Pharmaceutical Company, Inc. a specialty pharmaceutical company, engages in research and development, manufacture, and distribution of narcotic, pain-management, and addiction treatment pharmaceutical products primarily in the People's Republic of China. The company's principal products include Zhongtong'an, a capsule of herbal extraction for the indication of oral and dental pain; and Yiqi Qiangshen Granule, an OTC herbal extraction for tonifying qi and empowering body, and promoting blood circulation to remove meridian obstruction, as well as Tilidine hydrochloride, an orally-absorbed synthetic narcotic analgesic tablet used in 50mg or 100mg dosage for relief of acute, moderate to severe pain, and chronic cancer-related pain. Its products under development comprise Oxycodone and Acetaminophen tablets and capsules, which has completed clinical trials for the treatment of acute and chronic pain; Buprenorphine/Naloxone, a sublingual combo tablet that has completed Phase II clinical trials for the treatment of opioid dependence; and Tilidine/Naloxone, a compound capsule which is in Phase II clinical trial to treat acute and chronic pain. The company was formerly known as China Aoxing Pharmaceutical Company, Inc. and changed its name to Aoxing Pharmaceutical Company, Inc. in March 2010. Aoxing Pharmaceutical Company, Inc. is headquartered in Shijiazhuang, China.
axzyen.icm.cn346
Full Time Employees
June 30
Fiscal Year Ends
Sector
Recent News: AOXG
Performance Overview: AOXG
Trailing total returns as of 5/15/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: AOXG
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: AOXG
Valuation Measures
Market Cap
2.46M
Enterprise Value
2.46M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-4.86%
Return on Assets (ttm)
1.00%
Return on Equity (ttm)
-7.56%
Revenue (ttm)
30.11M
Net Income Avi to Common (ttm)
-1.46M
Diluted EPS (ttm)
-0.0000
Balance Sheet and Cash Flow
Total Cash (mrq)
7.08M
Total Debt/Equity (mrq)
153.29%
Levered Free Cash Flow (ttm)
264.81k
Research Analysis: AOXG
Company Insights: AOXG
AOXG does not have Company Insights